* Data in this page is the median value and it's updated daily. Sector and industry weightings are calculated using market capitalization which is converted to USD.
Ticker |
Company > |
PE Ratio | PE Ratio without NRI | Shiller PE Ratio | EV-to-EBIT | EV-to-EBITDA | EV-to-Revenue | PS Ratio | PB Ratio | Price-to-Tangible-Book | Price-to-Free-Cash-Flow | Price-to-Operating-Cash-Flow | Price-to-Median-PS-Value | Dividend Yield % | Dividend Payout Ratio | Gross Margin % | Net Margin % | Operating Margin % | Pre-Tax Margin % | ROE % | ROA % | ROC (Joel Greenblatt) % | ROIC % | WACC % | Altman Z-Score | Piotroski F-Score | Beneish M-Score | Debt-to-Equity | Cash-to-Debt | Equity-to-Asset | Days Sales Outstanding | Days Inventory | Days Payable | Cash Conversion Cycle | Forward Rate of Return (Yacktman) % | Current Ratio | Quick Ratio | Interest Coverage | Beta | 5-Year Revenue Growth Rate | 10-Year Revenue Growth Rate | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
APN.South africa | - | Aspen Pharmacare Holdings Ltd | 14.72 | 13.85 | 12.63 | 12.72 | 12.72 | 2.30 | 1.63 | 1.00 | 20.22 | 16.86 | 9.12 | 0.46 | 48.58 | 11.10 | 22.78 | 14.72 | 7.18 | 3.67 | 21.49 | 7.11 | 12.01 | 1.77 | 6 | -2.51 | 0.57 | 0.26 | 0.53 | 169.47 | 258.22 | 153.08 | 274.61 | -1.58 | 2.16 | 1.45 | 6.80 | 1.46 | 0.80 | 14.90 | |||
AIP.South africa | - | Adcock Ingram Holdings Ltd | 12.70 | 12.30 | 10.53 | 8.92 | 8.92 | 1.08 | 1.06 | 1.64 | 2.03 | 28.50 | 19.27 | 0.62 | 3.87 | 0.27 | 35.35 | 8.21 | 11.95 | 11.25 | 13.39 | 8.55 | 26.22 | 12.79 | 12.03 | 4.18 | 3 | -2.46 | 0.13 | 0.71 | 0.63 | 90.00 | 138.69 | 143.98 | 84.71 | 13.96 | 1.83 | 0.99 | 18.91 | 0.45 | 7.50 | 6.80 | |
SOT.Morocco | - | SOTHEMA | 32.31 | 9.31 | 8.22 | 1.85 | 3.50 | 6.77 | 7.43 | 1.89 | 51.87 | 13.42 | 21.04 | 19.55 | 26.98 | 14.87 | 36.61 | 23.34 | 7.52 | 5.91 | 4 | -1.69 | 0.15 | 0.22 | 0.54 | 99.16 | 228.29 | 166.34 | 161.11 | 2.15 | 1.07 | 57.60 | |||||||||||
PHAR.CA.Egypt | - | Egyptian International Pharmaceutical Investments | 8.03 | 8.21 | 8.04 | 6.63 | 6.63 | 1.09 | 1.34 | 1.37 | 1.37 | 24.52 | 10.20 | 0.81 | 41.78 | 16.75 | 20.70 | 17.78 | 10.32 | 17.43 | 7.64 | 1.73 | 5 | No Debt | 0.57 | 139.16 | 139.16 | 19.93 | 1.72 | 1.72 | 14.30 | 12.60 | |||||||||||
RMDA.CA.Egypt | - | Tenth Of Ramadan For Pharmaceutical Industries And | 19.93 | 21.42 | 11.74 | 9.54 | 2.96 | 2.03 | 1.64 | 2.01 | 46.51 | 11.68 | 19.18 | 15.11 | 8.68 | 5.38 | 14.10 | 7.30 | 8.25 | 2.53 | 4 | -1.87 | 0.77 | 0.02 | 0.53 | 92.52 | 195.63 | 46.99 | 241.16 | 1.51 | 1.20 | 1.91 | |||||||||||
PRO.Morocco | - | PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM | 8.80 | 6.44 | 1.26 | 1.57 | 2.46 | 2.49 | 50.08 | 9.09 | 16.44 | 14.24 | 15.27 | 9.66 | 38.53 | 23.51 | 7.60 | 5.54 | 6 | -2.19 | 506.11 | 0.64 | 46.46 | 189.26 | 189.47 | 46.25 | 2.33 | 1.38 | 247.36 | ||||||||||||||
GLAXOSMITH. | - | GlaxoSmithKline Consumer Nigeria PLC | 8.72 | 8.72 | 3.89 | 4.34 | 2.10 | 0.05 | 0.35 | 0.91 | 0.91 | 20.00 | 4.07 | 8.09 | 0.71 | 24.23 | 3.47 | 1.15 | 4.36 | 8.54 | 3.97 | 5.67 | 3.14 | 8.00 | 2.40 | 7 | No Debt | 0.40 | 84.54 | 113.76 | 11.96 | 186.34 | 1.51 | 1.17 | 3.52 | -4.90 | |||||||
ASC.South africa | - | Ascendis Health Ltd | -63.44 | 24.63 | 0.92 | 0.04 | 0.27 | 23.48 | 0.63 | 42.47 | -25.16 | 4.44 | -15.95 | -134.44 | -16.43 | -3.34 | 2.79 | 13.00 | 0.15 | 7 | -2.62 | 7.44 | 0.05 | 0.08 | 109.87 | 127.39 | 106.28 | 130.98 | -21.56 | 0.53 | 0.39 | 0.31 | 2.52 | 1.10 | |||||||||
SIPHA.Tunisia | - | Societe des Industries Pharmaceutiques de Tunisie- | 0.14 | 1.24 | |||||||||||||||||||||||||||||||||||||||
Average | 7.12 | 7.17 | 7.49 | -0.11 | 8.80 | 1.28 | 1.30 | 1.78 | 4.05 | 9.87 | 6.54 | 0.12 | 2.67 | 0.20 | 37.87 | 5.40 | 10.78 | 9.33 | -4.07 | 4.44 | 17.41 | 8.89 | 8.45 | 2.69 | 5 | -1.48 | 1.01 | 72.48 | 0.44 | 92.35 | 139.03 | 90.90 | 140.48 | 1.19 | 1.53 | 1.04 | 37.38 | 0.49 | 2.09 | 3.81 | |||
* All ratios are current value